These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 9827817

  • 1. High incidence of adeno- and polyomavirus-induced hemorrhagic cystitis in bone marrow allotransplantation for hematological malignancy following T cell depletion and cyclosporine.
    Childs R, Sanchez C, Engler H, Preuss J, Rosenfeld S, Dunbar C, van Rhee F, Plante M, Phang S, Barrett AJ.
    Bone Marrow Transplant; 1998 Nov; 22(9):889-93. PubMed ID: 9827817
    [Abstract] [Full Text] [Related]

  • 2. Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft.
    Herrera C, Torres A, García-Castellano JM, Roman J, Martin C, Serrano J, Falcon M, Alvarez MA, Gomez P, Martinez F.
    Bone Marrow Transplant; 1999 Mar; 23(5):443-50. PubMed ID: 10100557
    [Abstract] [Full Text] [Related]

  • 3. Hemorrhagic cystitis associated with urinary excretion of adenovirus type 11 following allogeneic bone marrow transplantation.
    Miyamura K, Takeyama K, Kojima S, Minami S, Matsuyama K, Morishima Y, Kodera Y.
    Bone Marrow Transplant; 1989 Sep; 4(5):533-5. PubMed ID: 2551434
    [Abstract] [Full Text] [Related]

  • 4. Risk factors for severe hemorrhagic cystitis following BMT.
    Seber A, Shu XO, Defor T, Sencer S, Ramsay N.
    Bone Marrow Transplant; 1999 Jan; 23(1):35-40. PubMed ID: 10037048
    [Abstract] [Full Text] [Related]

  • 5. Male predominance among Japanese adult patients with late-onset hemorrhagic cystitis after hematopoietic stem cell transplantation.
    Asano Y, Kanda Y, Ogawa N, Sakata-Yanagimoto M, Nakagawa M, Kawazu M, Goyama S, Kandabashi K, Izutsu K, Imai Y, Hangaishi A, Kurokawa M, Tsujino S, Ogawa S, Aoki K, Chiba S, Motokura T, Hirai H.
    Bone Marrow Transplant; 2003 Dec; 32(12):1175-9. PubMed ID: 14647272
    [Abstract] [Full Text] [Related]

  • 6. Early reactivation of cytomegalovirus and high risk of interstitial pneumonitis following T-depleted BMT for adults with hematological malignancies.
    Couriel D, Canosa J, Engler H, Collins A, Dunbar C, Barrett AJ.
    Bone Marrow Transplant; 1996 Aug; 18(2):347-53. PubMed ID: 8864445
    [Abstract] [Full Text] [Related]

  • 7. Primary BK virus (BKV) infection due to possible BKV transmission during bone marrow transplantation is not the major cause of hemorrhagic cystitis in transplanted children.
    Bogdanovic G, Priftakis P, Taemmeraes B, Gustafsson A, Flaegstad T, Winiarski J, Dalianis T.
    Pediatr Transplant; 1998 Nov; 2(4):288-93. PubMed ID: 10084731
    [Abstract] [Full Text] [Related]

  • 8. Clinicopathological features and risk factors of clinically overt haemorrhagic cystitis complicating bone marrow transplantation.
    Leung AY, Mak R, Lie AK, Yuen KY, Cheng VC, Liang R, Kwong YL.
    Bone Marrow Transplant; 2002 Mar; 29(6):509-13. PubMed ID: 11960271
    [Abstract] [Full Text] [Related]

  • 9. Higher risk of cytomegalovirus and aspergillus infections in recipients of T cell-depleted unrelated bone marrow: analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent graft-versus-host disease.
    van Burik JA, Carter SL, Freifeld AG, High KP, Godder KT, Papanicolaou GA, Mendizabal AM, Wagner JE, Yanovich S, Kernan NA.
    Biol Blood Marrow Transplant; 2007 Dec; 13(12):1487-98. PubMed ID: 18022579
    [Abstract] [Full Text] [Related]

  • 10. CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignancies.
    O'Donnell PV, Jones RJ, Vogelsang GB, Seber A, Ambinder RF, Flinn I, Miller C, Marcellus DC, Griffin C, Abrams R, Braine HG, Grever M, Hess AD, Piantadosi S, Noga SJ.
    Bone Marrow Transplant; 1998 Nov; 22(10):947-55. PubMed ID: 9849691
    [Abstract] [Full Text] [Related]

  • 11. Prostaglandin E2 bladder instillation for the treatment of hemorrhagic cystitis after allogeneic bone marrow transplantation.
    Laszlo D, Bosi A, Guidi S, Saccardi R, Vannucchi AM, Lombardini L, Longo G, Fanci R, Azzi A, De Santis R.
    Haematologica; 1995 Nov; 80(5):421-5. PubMed ID: 8566882
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Haemorrhagic cystitis in paediatric bone marrow transplant patients: an association with infective agents, GVHD and prior cyclophosphamide.
    Russell SJ, Vowels MR, Vale T.
    Bone Marrow Transplant; 1994 May; 13(5):533-9. PubMed ID: 8054906
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cyclosporine is required to prevent severe acute GVHD following T-cell-depleted peripheral blood stem cell transplantation.
    Solomon SR, Nakamura R, Read EJ, Leitman SF, Carter C, Childs R, Dunbar CE, Young NS, Barrett AJ.
    Bone Marrow Transplant; 2003 May; 31(9):783-8. PubMed ID: 12732885
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Adenovirus infection after pediatric bone marrow transplantation.
    Hale GA, Heslop HE, Krance RA, Brenner MA, Jayawardene D, Srivastava DK, Patrick CC.
    Bone Marrow Transplant; 1999 Feb; 23(3):277-82. PubMed ID: 10084260
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.